File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Health-Related Quality-Of-Life And Utility Measures Impact In A Randomized Controlled Study Of Fine Needle Aspiration Cytology (FNAC) Versus Watchful Observation In Patients With Incidental Symptomatic Thyroid Nodules

TitleHealth-Related Quality-Of-Life And Utility Measures Impact In A Randomized Controlled Study Of Fine Needle Aspiration Cytology (FNAC) Versus Watchful Observation In Patients With Incidental Symptomatic Thyroid Nodules
Authors
Issue Date2017
PublisherElsevier Inc. The Journal's web site is located at http://www.valueinhealthjournal.com/
Citation
International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress, Glasgow, UK, 4-8 November 2017. In Value in Health, 2017, v. 20 n. 9, p. A592 How to Cite?
AbstractObjectives: To present the impact of treatment on health-related quality-of-life (HRQOL) and health utility measures from the randomized controlled trial (ClinicalTrials.gov Identifier: NCT02398721) that investigated the FNAC versus watchful observation in patients with symptomatic benign thyroid nodules. Methods: Health utility and HRQOL were evaluated using the EuroQoL 5-dimension 5-level (EQ-5D-5L), 6-item Short Form Health Survey (SF-6D), cancer-specific Functional Assessment of Cancer Therapy-general (FACT-G) and generic 12-item Short Form Health Survey (SF-12v2) at baseline, 3-month, 6-month and 12-month assessments. A repeated measure analysis of variance (ANOVA) evaluated differences in HRQOL scores between treatment groups over time. Multiple imputation was used to impute missing data at each time point. Results: HRQOL data completion rates were 99.7% at baseline, 92.7% at 3-month, 93.9% at 6-month and 92.7% at 12-month after baseline. There were significant mean differences in SF-6D, EQ-5D-5L, FACT-G and SF-12v2 over time except PWB, EWB of FACT-G and mental health of SF-12v2. Mean change of utility scores from baseline between groups did not exceed minimal important difference. No significant treatment group by time interactions were found in all HRQOL and utility scores except in the vitality domain and PCS of SF-12v2 (p-value = 0.033; 0.024). Conclusions: When compared to watchful observation, FNAC intervention was associated with better vitality and physical-related HRQOL scores but did not provide better preservation of utility score improvement over the 12-month period.
Persistent Identifierhttp://hdl.handle.net/10722/250525
ISSN
2023 Impact Factor: 4.9
2023 SCImago Journal Rankings: 1.507
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorWong, CKH-
dc.contributor.authorLang, HHB-
dc.date.accessioned2018-01-18T04:28:28Z-
dc.date.available2018-01-18T04:28:28Z-
dc.date.issued2017-
dc.identifier.citationInternational Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress, Glasgow, UK, 4-8 November 2017. In Value in Health, 2017, v. 20 n. 9, p. A592-
dc.identifier.issn1098-3015-
dc.identifier.urihttp://hdl.handle.net/10722/250525-
dc.description.abstractObjectives: To present the impact of treatment on health-related quality-of-life (HRQOL) and health utility measures from the randomized controlled trial (ClinicalTrials.gov Identifier: NCT02398721) that investigated the FNAC versus watchful observation in patients with symptomatic benign thyroid nodules. Methods: Health utility and HRQOL were evaluated using the EuroQoL 5-dimension 5-level (EQ-5D-5L), 6-item Short Form Health Survey (SF-6D), cancer-specific Functional Assessment of Cancer Therapy-general (FACT-G) and generic 12-item Short Form Health Survey (SF-12v2) at baseline, 3-month, 6-month and 12-month assessments. A repeated measure analysis of variance (ANOVA) evaluated differences in HRQOL scores between treatment groups over time. Multiple imputation was used to impute missing data at each time point. Results: HRQOL data completion rates were 99.7% at baseline, 92.7% at 3-month, 93.9% at 6-month and 92.7% at 12-month after baseline. There were significant mean differences in SF-6D, EQ-5D-5L, FACT-G and SF-12v2 over time except PWB, EWB of FACT-G and mental health of SF-12v2. Mean change of utility scores from baseline between groups did not exceed minimal important difference. No significant treatment group by time interactions were found in all HRQOL and utility scores except in the vitality domain and PCS of SF-12v2 (p-value = 0.033; 0.024). Conclusions: When compared to watchful observation, FNAC intervention was associated with better vitality and physical-related HRQOL scores but did not provide better preservation of utility score improvement over the 12-month period.-
dc.languageeng-
dc.publisherElsevier Inc. The Journal's web site is located at http://www.valueinhealthjournal.com/-
dc.relation.ispartofValue in Health-
dc.rightsPosting accepted manuscript (postprint): © <year>. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.titleHealth-Related Quality-Of-Life And Utility Measures Impact In A Randomized Controlled Study Of Fine Needle Aspiration Cytology (FNAC) Versus Watchful Observation In Patients With Incidental Symptomatic Thyroid Nodules-
dc.typeConference_Paper-
dc.identifier.emailWong, CKH: carlosho@hku.hk-
dc.identifier.emailLang, HHB: Blang@hku.hk-
dc.identifier.authorityWong, CKH=rp01931-
dc.identifier.authorityLang, HHB=rp01828-
dc.identifier.doi10.1016/j.jval.2017.08.1099-
dc.identifier.hkuros284006-
dc.identifier.volume20-
dc.identifier.issue9-
dc.identifier.spageA592-
dc.identifier.epageA592-
dc.identifier.isiWOS:000413599901436-
dc.publisher.placeUnited States-
dc.identifier.issnl1098-3015-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats